پذیرفته شده و در حال انتشار                   برگشت به فهرست مقالات | برگشت به فهرست نسخه ها

Ethics code: REC.1394.303

XML English Abstract Print


چکیده:   (48 مشاهده)

Background: Gastric cancer (GC) is a significant global health concern, often diagnosed at advanced stages. While lincRNA-p21 has emerged as a potential biomarker in various cancers, its precise role in GC remains elusive.
Materials and Methods: This case-control study analyzed 40 matched pairs of tumor and non-tumor gastric samples, alongside gastric cancer cell lines. Total RNA extraction, cDNA synthesis, and real-time PCR were performed. Various cell lines, including NTERA2, AGS, MKN45, MDA-MB-231, FLO-1, OE-19, hiPSCs NP-40-8 and NP-41-17, and MSCs, were cultured to explore lincRNA-p21 expression across cancers and stem cells. Key cell cycle regulatory genes, including STAT3, CDK2, and E2F, were analyzed in gastric adenoma samples across various p53 statuses using the TCGA dataset via UALCAN database.
Results: Our findings indicate a significant decrease in lincRNA-p21 expression in tumor samples compared to non-tumor counterparts (P=0.01). LincRNA-p21 showed reduced expression across different malignancy grades. Additionally, analysis of gene expression in various cancer and stem cell lines consistently showed low levels of lincRNA-p21 expression rather than normal samples, suggesting its potential role in suppressing stemness and tumorigenesis. Further investigation into the lincRNA-p21-P21-P53 axis-regulated genes using TCGA data revealed a significant increase in their expression in both P53-mutated and non-mutated gastric adenocarcinoma compared to non-tumor samples.
Conclusion: The reduced levels of lincRNA-p21 and P21, along with elevated STAT3, CDK2, and E2F, indicate disrupted cell cycle control and tumorigenesis in gastric cancer. Consistent lincRNA-p21 downregulation across malignancy stages suggests its potential as an early prognostic biomarker for gastric cancer detection.

     
نوع مطالعه: مقاله پژوهشی | موضوع مقاله: Medical Biology
دریافت: 1403/11/23 | پذیرش: 1404/6/9 | انتشار: 1404/7/7

فهرست منابع
1. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635-48. [DOI:10.1016/S0140-6736(20)31288-5] [PMID]
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. [DOI:10.3322/caac.21660] [PMID]
3. Dykes IM, Emanueli C. Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA. Genom Proteom Bioinform. 2017;15(3):177-86. [DOI:10.1016/j.gpb.2016.12.005] [PMID] [PMCID]
4. Ciafrè SA, Russo M, Michienzi A, Galardi S. Long Noncoding RNAs and Cancer Stem Cells: Dangerous Liaisons Managing Cancer. Int J Mol Sci. 2023;24(3):1828. [DOI:10.3390/ijms24031828] [PMID] [PMCID]
5. Fischer M, Riege K, Hoffmann S. The landscape of human p53‐regulated long non‐coding RNAs reveals critical host gene co‐regulation. Mol Oncol. 2023;17(7):1263-79. [DOI:10.1002/1878-0261.13405] [PMID] [PMCID]
6. Bao X, Wu H, Zhu X, Guo X, Hutchins AP, Luo Z, et al. The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res. 2015;25(1):80-92. [DOI:10.1038/cr.2014.165] [PMID] [PMCID]
7. Huang Y, Yi Q, Feng J, Xie W, Sun W, Sun W. The role of lincRNA-p21 in regulating the biology of cancer cells. Hum Cell. 2022;35(6):1640-9. [DOI:10.1007/s13577-022-00768-4] [PMID]
8. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142(3):409-19. [DOI:10.1016/j.cell.2010.06.040] [PMID] [PMCID]
9. Dimitrova N, Zamudio JR, Jong RM, Soukup D, Resnick R, Sarma K, et al. LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint. Mol Cell. 2014;54(5):777-90. [DOI:10.1016/j.molcel.2014.04.025] [PMID] [PMCID]
10. Jia M, Jiang L, Wang YD, Huang JZ, Yu M, Xue HZ. lincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling-induced epithelial-mesenchymal transition. Hepatol Res. 2016;46(11):1137-44. [DOI:10.1111/hepr.12659] [PMID]
11. Yu F, Guo Y, Chen B, Shi L, Dong P, Zhou M, et al. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p. Cell Physiol Biochem. 2017;41(5):1970-80. [DOI:10.1159/000472410] [PMID]
12. Chen S, Liang H, Yang H, Zhou K, Xu L, Liu J, et al. LincRNa-p21: function and mechanism in cancer. Med Oncol. 2017;34(5):98. [DOI:10.1007/s12032-017-0959-5] [PMID]
13. Khalili M, Vasei M, Khalili D, Alimoghaddam K, Sadeghizadeh M, Mowla SJ. Downregulation of the Genes Involved in Reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in Gastric Adenocarcinoma. J Gastrointest Cancer. 2015;46(3):251-8. [DOI:10.1007/s12029-015-9695-2] [PMID]
14. Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18-27. [DOI:10.1016/j.neo.2022.01.001] [PMID] [PMCID]
15. Hall JR, Messenger ZJ, Tam HW, Phillips SL, Recio L, Smart RC. Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes. Cell Death Dis. 2015;6(3):e1700. [DOI:10.1038/cddis.2015.67] [PMID] [PMCID]
16. Yang N, Fu Y, Zhang H, Sima H, Zhu N, Yang G. LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma. Oncotarget. 2015;6(29):28151-63. [DOI:10.18632/oncotarget.4661] [PMID] [PMCID]
17. Zhai H, Fesler A, Schee K, Fodstad O, Flatmark K, Ju J. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clin Colorectal Cancer. 2013;12(4):261-6. [DOI:10.1016/j.clcc.2013.06.003] [PMID]
18. Işın M, Uysaler E, Özgür E, Köseoğlu H, Şanlı Ö, Yücel Ö B, et al. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front Genet. 2015;6:168. [DOI:10.3389/fgene.2015.00168] [PMID] [PMCID]
19. Wang X, Ruan Y, Wang X, Zhao W, Jiang Q, Jiang C, et al. Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer. Cell Prolif. 2017;50(2):e12318. [DOI:10.1111/cpr.12318] [PMID] [PMCID]
20. Isin M, Ozgur E, Cetin G, Erten N, Aktan M, Gezer U, et al. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta. 2014;431:255-9. [DOI:10.1016/j.cca.2014.02.010] [PMID]
21. Yang F, Zhang H, Mei Y, Wu M. Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect. Mol Cell. 2014;53(1):88-100. [DOI:10.1016/j.molcel.2013.11.004] [PMID]
22. Chen L, Yuan D, Yang Y, Ren M. LincRNA-p21 enhances the sensitivity of radiotherapy for gastric cancer by targeting the β-catenin signaling pathway. J Cell Biochem. 2019;120(4):6178-87. [DOI:10.1002/jcb.27905] [PMID]
23. Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, et al. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol Cancer. 2015;14(1):28. [DOI:10.1186/s12943-015-0295-3] [PMID] [PMCID]
24. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A, et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature. 2009;460(7259):1140-4. [DOI:10.1038/nature08311] [PMID] [PMCID]
25. Ma X, Yan W, Xu P, Ma L, Zan Y, Huang L, et al. LncRNA-p21 suppresses cell proliferation and induces apoptosis in gastric cancer by sponging miR-514b-3p and up-regulating ARHGEF9 expression. Biol Chem. 2022;403(10):945-58. [DOI:10.1515/hsz-2022-0153] [PMID]
26. Chen Y, Wei G, Xia H, Yu H, Tang Q, Bi F. Down regulation of lincRNA-p21 contributes to gastric cancer development through Hippo-independent activation of YAP. Oncotarget. 2017;8(38):63813-24. [DOI:10.18632/oncotarget.19130] [PMID] [PMCID]

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Journal of Advances in Medical and Biomedical Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb